Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Mosaic Biosciences

Request full access

Developer of synthetic extracellular materials used to support natural tissue regeneration

Boulder, United StatesFounded 2009Biotech & Life Sciences

About Mosaic Biosciences

Mosaic Biosciences is a cutting-edge biotechnology startup specializing in the discovery and development of therapeutic antibodies and proteins. The company leverages its proprietary Phage and Yeast Display libraries to accelerate the identification, characterization, and optimization of these therapeutic agents. Essentially, Mosaic Biosciences transforms initial concepts into viable drug candidates through its comprehensive discovery capabilities and a highly skilled multidisciplinary team.

The company serves a diverse range of clients, including startup companies, innovation or venture firms, biopharmaceutical companies, development-stage biopharmaceutical firms, and academic groups. These clients typically seek to accelerate their research, validate new ideas, or advance therapeutic programs to a more mature stage.

Operating in the biopharmaceutical market, Mosaic Biosciences employs a business model centered around partnerships. It collaborates with clients to advance antibody discovery projects from the initial concept stage to the identification of a preclinical candidate with validated pharmacology and drug-like properties. The company makes money through these partnerships by providing access to its advanced technology, expert scientists, and data-driven approach.

Mosaic Biosciences also offers a range of analytical services to assess the quality of materials produced internally. These services include biophysical, biochemical, and bioanalytical techniques such as High-Performance Liquid Chromatography (HPLC), interferometry, and plate-based methods to measure purity and other critical parameters.

In summary, Mosaic Biosciences is a dynamic player in the biotech industry, providing end-to-end solutions for the discovery and development of therapeutic antibodies and proteins. Its innovative approach and robust technology platform make it a valuable partner for various stakeholders in the biopharmaceutical ecosystem.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2009
Headquarters
Boulder, United States
Employees
47
Open positions
None listed
Dealroom signal
63.5/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, proteomics, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Jun 2022 $11M $46M Dan Mitchell · Telegraph Hill Partners ↗
GRANT✓Other financing May 2021 $242K — Colorado Office of Economic Development and International Trade ↗
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Mosaic Biosciences website traffic

Latest recorded traffic for Mosaic Biosciences is 2.5K monthly website visits, down 34.2% over the last three months. Mosaic Biosciences's team declined 11.3% over the past year.

Latest monthly visits2.5K 3-month web change-34.2% 1-year team growth-11.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Engimmune TherapeuticsPlatform and product development company engineering next-generation T cell receptor therapies Allschwil, Switzerland Operational 12 $15M $57M
Stratus TherapeuticsDeveloping off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases Natick, United States Operational
Nabla BioDeveloping AI and wet-lab technologies to enable the rational design of selective, functional drugs targeting previously undruggable sites Cambridge, United States Operational
Nereid TherapeuticsA pioneer of the biomolecular condensate field and one of the world’s leading experts in intracellular liquid-liquid phase separation Boston, United States Operational
Aperiam BioTaking the guesswork out of biotechnology with computer vision that illuminates critical parts of protein chemistry New York City, United States Operational
PRAMOMOLECULARDeveloping innovative self-delivering siRNAs to silence the formation of disease-causing proteins to improve the treatment of lung and pancreatic cancer Berlin, Germany Operational
Juvena TherapeuticsA biopharmaceutical platform which is discovering novel protein-based therapeutics Palo Alto, United States Operational
FimecsTargeted protein degradation therapeutics for undruggable diseases Fujisawa, Japan Acquired
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Mosaic Biosciences in the Boulder ecosystem

Live from Dealroom

The Mosaic Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Colorado Office of Economic Development and International Trade

Series A5 investors entered at this stage

  • Morgenthaler Ventures
  • HealthCare Ventures
  • High Country Venture
  • Telegraph Hill Partners
  • Dan Mitchell

Other known investors2 additional known investors

  • University of Colorado Boulder
  • Lightstone Ventures
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇺🇸 United States93%
🇧🇷 Brazil2.3%
🇬🇧 United Kingdom2.3%
🇳🇱 Netherlands2.3%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Mosaic Biosciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Mosaic Biosciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.